← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2007Last known activity
Oct 8, 2024
Timeline
2000s
- Jun 1, 2001
Kael-GemVax Co., Ltd.— Founded
- Dec 1, 2008
Onyvax— Acquired
Drugs by trial phase (5 distinct, 12 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (17)
- NCT06625710Lead sponsorPhase 1Oct 8, 2024
- NCT06235775OfficialPhase 2Dec 12, 2023
- NCT06235775Lead sponsorPhase 2Dec 12, 2023
- NCT05819658Study chairPhase 2Jun 14, 2023
- NCT05819658Lead sponsorPhase 2Jun 14, 2023
- NCT05303701Lead sponsorPhase 3Jan 1, 2023
- NCT05303701Study directorPhase 3Jan 1, 2023
- NCT05189210Study directorPhase 2Oct 5, 2022
- NCT05189210Lead sponsorPhase 2Oct 5, 2022
- NCT03959553Lead sponsorPhase 2Sep 1, 2019
- NCT03184467Study directorPhase 2Jun 1, 2017
- NCT03184467Lead sponsorPhase 2Jun 1, 2017
- NCT02855892Lead sponsorPhase 2Oct 1, 2015
- NCT01579188Lead sponsorPhase 3May 1, 2012
- NCT01579188Study directorPhase 3May 1, 2012
Details
- Founded
- Bundang-gu, KR Jun 1, 2001
- Last known activity
- Oct 8, 2024